Please enable JavaScript to continue using this application.

Compare $AVTR vs $BIO | Chartloom

Compare

$AVTR vs $BIO

Avantor Inc · Bio Rad Laboratories Inc

AVTR

Avantor Inc

BIO

Bio Rad Laboratories Inc

Compare $AVTR vs $BIO

Comparing Avantor Inc and Bio Rad Laboratories Inc

AVTRAvantor Inc

BIOBio Rad Laboratories Inc

AVTRAvantor Inc

Market cap

$10.60B

P/E (TTM)

—

Forward P/E (NTM)

17.83x

Forward P/S (NTM)

1.56x

Rev growth (TTM)

-1.6%

YTD performance

36.7%

52W performance

14.0%

FCF yield

4.3%

BIOBio Rad Laboratories Inc

Market cap

$9.80B

P/E (TTM)

44.15x

Forward P/E (NTM)

33.67x

Forward P/S (NTM)

3.70x

Rev growth (TTM)

1.4%

YTD performance

19.9%

52W performance

20.9%

FCF yield

3.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVTR

BIO

Detailed metrics comparison

AVTR

Avantor Inc

BIO

Bio Rad Laboratories Inc

Market Cap

AVTR$10.60B

BIO$9.80B

Enterprise Value

AVTR$13.99B

BIO$10.49B

Price

AVTR$15.67

BIO$366.16

P/E Ratio

AVTRN/A

BIO44.15x

P/S Ratio

AVTR1.62x

BIO3.78x

EV/Sales

AVTR2.13x

BIO4.05x

EV/EBITDA

AVTR15.42x

BIO15.48x

P/B Ratio

AVTR1.84x

BIO1.38x

P/FCF Ratio

AVTR23.31x

BIO27.75x

EV/FCF

AVTR30.77x

BIO29.69x

PEG Ratio

AVTRN/A

BION/A

Forward P/E (NTM)

AVTR17.83x

BIO33.67x

Forward P/S (NTM)

AVTR1.56x

BIO3.70x

Revenue (TTM)

AVTR$6.56B

BIO$2.59B

Revenue Growth (YoY)

AVTR-1.6%

BIO1.4%

Forward Rev Growth

AVTR2.3%

BIO2.9%

Gross Margin (TTM)

AVTR31.8%

BIO51.9%

Operating Margin (TTM)

AVTR0.0%

BIO1.8%

EBITDA Margin (TTM)

AVTR13.8%

BIO9.1%

Net Margin (TTM)

AVTR-8.8%

BIO8.6%

FCF Margin (TTM)

AVTR6.9%

BIO13.6%

Net Income (TTM)

AVTR$-578M

BIO$222M

FCF (TTM)

AVTR$455M

BIO$353M

EPS (TTM)

AVTR-$0.85

BIO$8.29

ROE (TTM)

AVTR-1034.0%

BIO3.1%

ROA (TTM)

AVTR-495.0%

BIO2.2%

ROIC (TTM)

AVTR-614.0%

BIO2.7%

Cash

AVTR$307M

BIO$517M

Debt

AVTR$3.70B

BIO$1.20B

Net Cash/Debt

AVTR$-3.39B

BIO$-687M

Current Ratio (TTM)

AVTR1.78x

BIO3.14x

Quick Ratio (TTM)

AVTR1.18x

BIO2.18x

Debt/Equity (TTM)

AVTR0.66x

BIO0.17x

Debt/Assets (TTM)

AVTR0.0%

BIO0.0%

Interest Coverage (TTM)

AVTRN/A

BION/A

Net Debt/EBITDA (TTM)

AVTR0.00x

BIO0.00x

Beta

AVTR0.98

BIO1.07

52W Performance

AVTR14.0%

BIO20.9%

YTD Performance

AVTR36.7%

BIO19.9%

% from 52W High

AVTR-4.3%

BIO-7.6%

% from 52W Low

AVTR115.7%

BIO54.7%

Asset Turnover (TTM)

AVTR0.56x

BIO0.26x

FCF Yield (TTM)

AVTR4.3%

BIO3.6%

Earnings Yield (TTM)

AVTR-5.5%

BIO2.3%

Dividend Yield (TTM)

AVTRN/A

BION/A

Rule of 40

AVTR5.4

BIO15.0

EV/GP/RG

AVTR1.90

BIO1.18

Ticker research

View AVTR research View BIO research

Metric	AVTR Avantor Inc	BIO Bio Rad Laboratories Inc
Market & Valuation
Market Cap	$10.60B	$9.80B
Enterprise Value	$13.99B	$10.49B
Price	$15.67	$366.16
P/E Ratio	N/A	44.15x
P/S Ratio	1.62x	3.78x
EV/Sales	2.13x	4.05x
EV/EBITDA	15.42x	15.48x
P/B Ratio	1.84x	1.38x
P/FCF Ratio	23.31x	27.75x
EV/FCF	30.77x	29.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	17.83x	33.67x
Forward P/S (NTM)	1.56x	3.70x
Revenue & Growth
Revenue (TTM)	$6.56B	$2.59B
Revenue Growth (YoY)	-1.6%	1.4%
Forward Rev Growth	2.3%	2.9%
Profitability
Gross Margin (TTM)	31.8%	51.9%
Operating Margin (TTM)	0.0%	1.8%
EBITDA Margin (TTM)	13.8%	9.1%
Net Margin (TTM)	-8.8%	8.6%
FCF Margin (TTM)	6.9%	13.6%
Net Income (TTM)	$-578M	$222M
FCF (TTM)	$455M	$353M
EPS (TTM)	-$0.85	$8.29
ROE (TTM)	-1034.0%	3.1%
ROA (TTM)	-495.0%	2.2%
ROIC (TTM)	-614.0%	2.7%
Financial Health
Cash	$307M	$517M
Debt	$3.70B	$1.20B
Net Cash/Debt	$-3.39B	$-687M
Current Ratio (TTM)	1.78x	3.14x
Quick Ratio (TTM)	1.18x	2.18x
Debt/Equity (TTM)	0.66x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	1.07
52W Performance	14.0%	20.9%
YTD Performance	36.7%	19.9%
% from 52W High	-4.3%	-7.6%
% from 52W Low	115.7%	54.7%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.26x
FCF Yield (TTM)	4.3%	3.6%
Earnings Yield (TTM)	-5.5%	2.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	15.0
EV/GP/RG	1.90	1.18
Ticker research	View AVTR research	View BIO research

Valuation

P/E Ratio

BIO

44.15x

P/S Ratio

AVTR

1.62x

BIO

3.78x

EV/FCF

BIO

29.69x

AVTR

30.77x

Growth & revenue

Revenue Growth TTM

BIO

1.4%

AVTR

-1.6%

Forward Revenue Growth

BIO

2.9%

AVTR

2.3%

Profitability & performance

Gross Margin

BIO

51.9%

AVTR

31.8%

ROE

BIO

3.1%

AVTR

-1034.0%

FCF Yield %

AVTR

4.3%

BIO

3.6%

52-Week Performance

BIO

20.9%

AVTR

14.0%

Detailed metrics comparison

AVTR

Avantor Inc

BIO

Bio Rad Laboratories Inc

Market Cap

AVTR$10.60B

BIO$9.80B

Enterprise Value

AVTR$13.99B

BIO$10.49B

Price

AVTR$15.67

BIO$366.16

P/E Ratio

AVTRN/A

BIO44.15x

P/S Ratio

AVTR1.62x

BIO3.78x

EV/Sales

AVTR2.13x

BIO4.05x

EV/EBITDA

AVTR15.42x

BIO15.48x

P/B Ratio

AVTR1.84x

BIO1.38x

P/FCF Ratio

AVTR23.31x

BIO27.75x

EV/FCF

AVTR30.77x

BIO29.69x

PEG Ratio

AVTRN/A

BION/A

Forward P/E (NTM)

AVTR17.83x

BIO33.67x

Forward P/S (NTM)

AVTR1.56x

BIO3.70x

Revenue (TTM)

AVTR$6.56B

BIO$2.59B

Revenue Growth (YoY)

AVTR-1.6%

BIO1.4%

Forward Rev Growth

AVTR2.3%

BIO2.9%

Gross Margin (TTM)

AVTR31.8%

BIO51.9%

Operating Margin (TTM)

AVTR0.0%

BIO1.8%

EBITDA Margin (TTM)

AVTR13.8%

BIO9.1%

Net Margin (TTM)

AVTR-8.8%

BIO8.6%

FCF Margin (TTM)

AVTR6.9%

BIO13.6%

Net Income (TTM)

AVTR$-578M

BIO$222M

FCF (TTM)

AVTR$455M

BIO$353M

EPS (TTM)

AVTR-$0.85

BIO$8.29

ROE (TTM)

AVTR-1034.0%

BIO3.1%

ROA (TTM)

AVTR-495.0%

BIO2.2%

ROIC (TTM)

AVTR-614.0%

BIO2.7%

Cash

AVTR$307M

BIO$517M

Debt

AVTR$3.70B

BIO$1.20B

Net Cash/Debt

AVTR$-3.39B

BIO$-687M

Current Ratio (TTM)

AVTR1.78x

BIO3.14x

Quick Ratio (TTM)

AVTR1.18x

BIO2.18x

Debt/Equity (TTM)

AVTR0.66x

BIO0.17x

Debt/Assets (TTM)

AVTR0.0%

BIO0.0%

Interest Coverage (TTM)

AVTRN/A

BION/A

Net Debt/EBITDA (TTM)

AVTR0.00x

BIO0.00x

Beta

AVTR0.98

BIO1.07

52W Performance

AVTR14.0%

BIO20.9%

YTD Performance

AVTR36.7%

BIO19.9%

% from 52W High

AVTR-4.3%

BIO-7.6%

% from 52W Low

AVTR115.7%

BIO54.7%

Asset Turnover (TTM)

AVTR0.56x

BIO0.26x

FCF Yield (TTM)

AVTR4.3%

BIO3.6%

Earnings Yield (TTM)

AVTR-5.5%

BIO2.3%

Dividend Yield (TTM)

AVTRN/A

BION/A

Rule of 40

AVTR5.4

BIO15.0

EV/GP/RG

AVTR1.90

BIO1.18

Ticker research

View AVTR research View BIO research

Metric	AVTR Avantor Inc	BIO Bio Rad Laboratories Inc
Market & Valuation
Market Cap	$10.60B	$9.80B
Enterprise Value	$13.99B	$10.49B
Price	$15.67	$366.16
P/E Ratio	N/A	44.15x
P/S Ratio	1.62x	3.78x
EV/Sales	2.13x	4.05x
EV/EBITDA	15.42x	15.48x
P/B Ratio	1.84x	1.38x
P/FCF Ratio	23.31x	27.75x
EV/FCF	30.77x	29.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	17.83x	33.67x
Forward P/S (NTM)	1.56x	3.70x
Revenue & Growth
Revenue (TTM)	$6.56B	$2.59B
Revenue Growth (YoY)	-1.6%	1.4%
Forward Rev Growth	2.3%	2.9%
Profitability
Gross Margin (TTM)	31.8%	51.9%
Operating Margin (TTM)	0.0%	1.8%
EBITDA Margin (TTM)	13.8%	9.1%
Net Margin (TTM)	-8.8%	8.6%
FCF Margin (TTM)	6.9%	13.6%
Net Income (TTM)	$-578M	$222M
FCF (TTM)	$455M	$353M
EPS (TTM)	-$0.85	$8.29
ROE (TTM)	-1034.0%	3.1%
ROA (TTM)	-495.0%	2.2%
ROIC (TTM)	-614.0%	2.7%
Financial Health
Cash	$307M	$517M
Debt	$3.70B	$1.20B
Net Cash/Debt	$-3.39B	$-687M
Current Ratio (TTM)	1.78x	3.14x
Quick Ratio (TTM)	1.18x	2.18x
Debt/Equity (TTM)	0.66x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	1.07
52W Performance	14.0%	20.9%
YTD Performance	36.7%	19.9%
% from 52W High	-4.3%	-7.6%
% from 52W Low	115.7%	54.7%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.26x
FCF Yield (TTM)	4.3%	3.6%
Earnings Yield (TTM)	-5.5%	2.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	15.0
EV/GP/RG	1.90	1.18
Ticker research	View AVTR research	View BIO research